There are 807 resources available
274MO - Mobile application for breast cancer survivors to improve their post treatment quality of life: A randomized controlled trial
Presenter: Maninder Kaur
Session: Mini Oral session: Supportive and palliative care
Resources:
Abstract
Slides
157O - Biomarker analysis and updated results from the phase III PROpel trial of abiraterone (abi) and olaparib (ola) vs abi and placebo (pbo) as first-line (1L) therapy for patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
Presenter: Fred Saad
Session: Proffered Paper session: Genitourinary tumours
Resources:
Abstract
Slides
Webcast
Locally advanced and recurrent cervical cancer
Presenter: Ana Oaknin
Session: Immunotherapy in gynecological cancers: Where do we stand?
Resources:
Slides
Webcast
Breast: State of the art in 2022
Presenter: Yong Bae Kim
Session: Hypofractionation in radiotherapy
Resources:
Slides
Webcast
Individualising treatments for oncogene addicted lung cancer
Presenter: Tony S.K. Mok
Session: Lung cancer in non-smokers
Resources:
Slides
Webcast
YO9 - Primary refractoriness of recurrent ovarian clear cell carcinoma to anti–PD-1 inhibitor-based therapy in a patient with Lynch syndrome: Never take for granted
Presenter: Jack Chan
Session: Unusual challenges in clinical oncology: YO case discussions
Resources:
Abstract
Slides
Webcast
Invited Discussant 135O and 157O
Presenter: Enrique Grande Pulido
Session: Proffered Paper session: Genitourinary tumours
Resources:
Slides
Webcast
Invited Discussant 273MO and 274MO
Presenter: Paolo Bossi
Session: Mini Oral session: Supportive and palliative care
Resources:
Slides
Webcast
Advanced and recurrent endometrial cancer
Presenter: Domenica Lorusso
Session: Immunotherapy in gynecological cancers: Where do we stand?
Resources:
Slides
Webcast
Prostate: State of the art in 2022
Presenter: Melvin Lee Kiang Chua
Session: Hypofractionation in radiotherapy
Resources:
Slides
Webcast